Letter to the Editor: A critical issue surrounding the Medicare Part D program
There is a critical issue surrounding the Medicare Part D program, specifically as it relates to coverage.
fda
Powdered Infant Formula Recalled, FDA Warns Consumers Not to Use Certain Powdered Infant Formulas
The North Carolina Department of Health and Human Services is cautioning families about certain infant formula that has been recalled by Abbott for potentially containing a bacteria that can lead to hospitalization in infants. The recall includes powdered formulas Similac, Alimentum, EleCare and EleCare Jr., and they should not be used.
Wait time for Moderna COVID-19 booster shortened to five months
The FDA now authorizes and the Centers for Disease Control and Prevention recommends individuals who received the Moderna COVID-19 vaccine get a booster dose after five months. This announcement from federal agencies comes just three days after the announcement of a shortened wait time for a booster from six months to five months for individuals who received the Pfizer vaccine.
FDA shortens interval for Booster dose of Moderna COVID-19 vaccine to five months
The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least five months for individuals 18 years of age and older.
FDA authorizes first oral antiviral for treatment of COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death
COVID-19 booster shots now available for all vaccinated adults
The Centers for Disease Control and Prevention recommends anyone 18 years or older who received the Pfizer or Moderna COVID-19 vaccine get a booster six months after their second dose to help strengthen and extend protections against COVID-19. This comes after the Food and Drug Administration authorized the boosters for such use today.
Governor Cooper tours pediatric office to highlight eligibility for children 5-11 to receive COVID-19 vaccine
Governor Roy Cooper and North Carolina Department of Health and Human Services (NCDHHS) Secretary Mandy K. Cohen, M.D. toured Chapel Hill Pediatrics and Adolescents, P.A. in Orange County to see their operations to vaccinate children ages 5-11. The pediatrician’s office will begin administering vaccines for children ages 5-11, following the Food and Drug Administration’s (FDA) authorization of a lower dose of the Pfizer-BioNTech COVID-19 vaccine for children and the Center for Disease Control and Prevention’s (CDC) recommendation that children ages 5–11 receive the vaccine.
Governor Cooper provides positive update on State’s COVID-19 trends, Encourages vaccination
Governor Roy Cooper and North Carolina Department of Health and Human Services Secretary Mandy K. Cohen, M.D. provided an update on the state’s COVID-19 key metrics and trends.
Pfizer COVID-19 Booster Shots Available for High-Risk Groups
To strengthen and extend protections against severe illness, North Carolinians at high risk for serious illness or exposure, and who have been fully vaccinated with the Pfizer-BioNTech (COMINARTY) vaccine for six months or more, can now receive a COVID-19 booster shot.
FDA approves Pfizer vaccine for those 16 and older
The Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine, which will Pfizer is calling Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older.
Bill that frees up pharmacists, requires parental consent for vaccines, heads to governor
The N.C. House on Thursday, Aug. 5, concurred with the Senate on a bill giving parents control over the COVID vaccine.
Leading Cell Therapy Biotech Company chooses Research Triangle for its North American research and development and manufacturing facility
CARsgen Therapeutics Corporation, an innovative biotechnology company pursuing medicines to treat cancer will create approximately 200 jobs and invest $157 million in Durham, Governor Roy Cooper announced today.